Top

Journal of Behavioral Medicine

Gepubliceerd in:

06-05-2023

Development of a targeted behavioral treatment for smoking cessation among individuals with Chronic Obstructive Pulmonary Disease

Auteurs: Amanda R. Mathew, Elizabeth F. Avery, Chelsea Cox, Patrick Nwanah, Ravi Kalhan, Brian Hitsman, Lynda H. Powell

Gepubliceerd in: Journal of Behavioral Medicine | Uitgave 6/2023

Abstract

Objective

Smoking cessation for individuals with Chronic Obstructive Pulmonary Disease (COPD) is medically critical, but smoking for coping motives is a common barrier.

Method

In this evaluation of three treatment components (Mindfulness, Practice Quitting, and Countering Emotional Behaviors), we conducted two studies guided by the ORBIT model. Study 1 was a single-case design experiment (N = 18); Study 2 was a pilot feasibility study (N = 30). In both studies, participants were randomized to receive one of the three treatment modules. Study 1 examined implementation targets, changes in smoking for coping motives, and changes in smoking rate. Study 2 examined overall feasibility and participant-rated acceptability, and changes in smoking rate.

Results

Study 1: Treatment implementation targets were met by 3/5 Mindfulness participants, 2/4 Practice Quitting participants, and 0/6 Countering Emotional Behaviors participants. The Practice Quitting condition led to 100% of participants meeting the clinically significant threshold in smoking for coping motives. Incidence of quit attempts ranged from 0–50%, and smoking rate was reduced by 50% overall. Study 2: Recruitment and retention met feasibility targets, with 97% of participants completing all four treatment sessions. Participants reported high treatment satisfaction by qualitative responses and rating scales (M = 4.8/ 5.0). Incidence of quit attempts ranged from 25–58%, and smoking rate was reduced by 56% overall.

Conclusions

These two small-N studies provide complementary findings on internal validity and implementation of the novel intervention. While Study 1 provided initial support for plausibility of clinically significant change, Study 2 provided data on key feasibility parameters.

Implications

Smoking cessation for individuals with COPD is medically critical. We conducted an early-phase evaluation of a novel behavioral treatment focused on reducing smoking for coping motives. Results provided initial support for plausibility of clinically significant change and feasibility of the intervention.

vorige artikel Adversity type and timing predict temporal summation of pain in African-American adults

volgende artikel Death anxiety predicts fear of Cancer recurrence and progression in ovarian Cancer patients over and above other cognitive factors

Alleen toegankelijk voor geautoriseerde gebruikers

Arbeau, K. J., Kuiken, D., & Wild, T. C. (2011). Drinking to enhance and to cope: A daily process study of motive specificity. Addictive Behaviors, 36(12), 1174–1183.PubMedCrossRef

Ashare, R. L., Wileyto, E. P., Perkins, K. A., & Schnoll, R. A. (2013). The First Seven Days of a Quit Attempt Predicts Relapse: Validation of a Measure for Screening Medications for Nicotine Dependence. Journal of Addiction Medicine, 7(4), 249–254.PubMedPubMedCentralCrossRef

Baker, T. B., Mermelstein, R., Collins, L. M., Piper, M. E., Jorenby, D. E., Smith, S. S., & Fiore, M. C. (2011). New methods for tobacco dependence treatment research. Annals of Behavioral Medicine, 41(2), 192–207.PubMedCrossRef

Baker, T. B., Piper, M. E., McCarthy, D. E., Majeskie, M. R., & Fiore, M. C. (2004). Addiction motivation reformulated: an affective processing model of negative reinforcement. Psychological review, 111(1), 33.PubMedCrossRef

Barlow, D. H., Farchione, T. J., Fairholme, C. P., Ellard, K. K., Boisseau, C. L., Allen, L. B., & May, J. T. E. (2010). Unified protocol for transdiagnostic treatment of emotional disorders: Therapist guide. Oxford University Press.

Barlow, D. H. N., Hersen, M., Barlow, M. D., Nock, M., & Hersen, M. (2009). Single case experimental designs: Strategies for studying behavior for change.

Biener, L., & Abrams, D. B. (1991). The Contemplation Ladder: validation of a measure of readiness to consider smoking cessation. Health Psychology, 10(5), 360.PubMedCrossRef

Blevins, C. E., Banes, K. E., Stephens, R. S., Walker, D. D., & Roffman, R. A. (2016). Change in motives among frequent cannabis-using adolescents: Predicting treatment outcomes. Drug and Alcohol Dependence.

Blevins, C. E., & Stephens, R. S. (2016). The impact of motives-related feedback on drinking to cope among college students. Addictive Behaviors, 58, 68–73.PubMedCrossRef

Bowen, D. J., Kreuter, M., Spring, B., Cofta-Woerpel, L., Linnan, L., Weiner, D., & Fabrizio, C. (2009). How we design feasibility studies. American journal of preventive medicine, 36(5), 452–457.PubMedPubMedCentralCrossRef

Brake, C. A., Sauer-Zavala, S., Boswell, J. F., Gallagher, M. W., Farchione, T. J., & Barlow, D. H. (2016). Mindfulness-Based Exposure Strategies as a Transdiagnostic Mechanism of Change: An Exploratory Alternating Treatment Design. Behavior therapy, 47(2), 225–238.PubMedCrossRef

Brown, R. A., Lejuez, C., Kahler, C. W., Strong, D. R., & Zvolensky, M. J. (2005). Distress tolerance and early smoking lapse. Clinical Psychology Review, 25(6), 713–733.PubMedPubMedCentralCrossRef

Brown, R. A., Lejuez, C., Strong, D. R., Kahler, C. W., Zvolensky, M. J., Carpenter, L. L., & Price, L. H. (2009). A prospective examination of distress tolerance and early smoking lapse in adult self-quitters.Nicotine & Tobacco Research,ntp041.

Busch, A. M., Uebelacker, L. A., Kalibatseva, Z., & Miller, I. W. (2010). Measuring homework completion in behavioral activation. Behavior Modification, 34(4), 310–329.PubMedPubMedCentralCrossRef

Cassiello-Robbins, C., Southward, M. W., Tirpak, J. W., & Sauer-Zavala, S. (2020). A systematic review of Unified Protocol applications with adult populations: Facilitating widespread dissemination via adaptability. Clinical Psychology Review, 78, 101852.PubMedCrossRef

Comeau, N., Stewart, S., Loba, P., Rhyno, E., & Loughlin, H. (2000). Adolescents’ motives for smoking and marijuana use: Factor structure and relations to motives for alcohol use Paper presented at the New research on human motivations for alcohol use. Symposium conducted at the 3 rd Joint Meeting of the British Experimental Psychology Society and the Canadian Society for Brain Behavior, and Cognitive Science, Cambridge, UK.

Cook, J., Spring, B., McChargue, D., & Doran, N. (2010). Effects of anhedonia on days to relapse among smokers with a history of depression: a brief report. Nicotine & Tobacco Research, 12(9), 978–982.CrossRef

Cook, J. W., Piper, M. E., Leventhal, A. M., Schlam, T. R., Fiore, M. C., & Baker, T. B. (2015). Anhedonia as a component of the tobacco withdrawal syndrome. Journal of abnormal psychology, 124(1), 215.PubMedCrossRef

Czajkowski, S. M., Powell, L. H., Adler, N., Naar-King, S., Reynolds, K. D., Hunter, C. M., & Peterson, J. C. (2015). From ideas to efficacy: The ORBIT model for developing behavioral treatments for chronic diseases. Health Psychology, 34(10), 971.PubMedPubMedCentralCrossRef

Dvorak, R. D., Pearson, M. R., & Day, A. M. (2014). Ecological momentary assessment of acute alcohol use disorder symptoms: Associations with mood, motives, and use on planned drinking days. Experimental and Clinical Psychopharmacology, 22(4), 285.PubMedPubMedCentralCrossRef

Fiore, M. C., Jaen, C. R., Baker, T. B., Bailey, W. C., Bennett, G., Benowitz, N. L., & Dorfman, S. (2008). A clinical practice guideline for treating tobacco use and dependence: 2008 update. A US Public Health Service report. American Journal of Preventive Medicine, 35(2), 158–176.CrossRef

Gale, R. C., Wu, J., Erhardt, T., Bounthavong, M., Reardon, C. M., Damschroder, L. J., & Midboe, A. M. (2019). Comparison of rapid vs in-depth qualitative analytic methods from a process evaluation of academic detailing in the Veterans Health Administration. Implementation Science, 14(1), 1–12.CrossRef

Gifford, E. V., Kohlenberg, B. S., Hayes, S. C., Antonuccio, D. O., Piasecki, M. M., Rasmussen-Hall, M. L., & Palm, K. M. (2004). Acceptance-based treatment for smoking cessation. J B t, 35(4), 689–705.

Godtfredsen, N. S., Lam, T. H., Hansel, T. T., Leon, M. E., Gray, N., Dresler, C., & Vestbo, J. (2008). COPD-related morbidity and mortality after smoking cessation: status of the evidence. European Respiratory Journal, 32(4), 844–853.PubMedCrossRef

Goodwin, R. D., Lavoie, K. L., Lemeshow, A. R., Jenkins, E., Brown, E. S., & Fedoronko, D. A. (2012). Depression, anxiety, and COPD: the unexamined role of nicotine dependence. Nicotine & Tobacco Research, 14(2), 176–183.CrossRef

Grant, V. V., Stewart, S. H., & Mohr, C. D. (2009). Coping-anxiety and coping-depression motives predict different daily mood-drinking relationships. Psychology of Addictive Behaviors, 23(2), 226.PubMedCrossRef

Grant, V. V., Stewart, S. H., O'Connor, R. M., Blackwell, E., & Conrod, P. J. (2007). Psychometric evaluation of the five-factor Modified Drinking Motives Questionnaire—Revised in undergraduates. Addictive Behaviors, 32(11), 2611–2632.PubMedCrossRef

Group, T. S. (2004). The TORCH (towards a revolution in COPD health) survival study protocol. European Respiratory Journal, 24(2), 206–210.CrossRef

Hartmann-Boyce, J., Livingstone-Banks, J., Ordóñez-Mena, J. M., Fanshawe, T. R., Lindson, N., Freeman, S. C., & Aveyard, P. (2020). Behavioural interventions for smoking cessation: an overview and network meta-analysis. Cochrane database of systematic reviews(12).

Hendricks, P. S., Ditre, J. W., Drobes, D. J., & Brandon, T. H. (2006). The early time course of smoking withdrawal effects. Psychopharmacology (Berl), 187(3), 385–396.PubMedCrossRef

Hughes, J. R. (2007). Effects of abstinence from tobacco: etiology, animal models, epidemiology, and significance: a subjective review. Nicotine & Tobacco Research, 9(3), 329–339.CrossRef

Hughes, J. R., & Carpenter, M. J. (2006). Does smoking reduction increase future cessation and decrease disease risk? A qualitative review. Nicotine & Tobacco Research, 8(6), 739–749.CrossRef

Javors, M. A., Hatch, J. P., & Lamb, R. J. (2005). Cut-off levels for breath carbon monoxide as a marker for cigarette smoking. Addiction, 100(2), 159–167.PubMedCrossRef

Jimenez-Ruiz, C. A., Masa, F., Miravitlles, M., Gabriel, R., Viejo, J. L., Villasante, C., & Sobradillo, V. (2001). Smoking characteristics: differences in attitudes and dependence between healthy smokers and smokers with COPD. Chest, 119(5), 1365–1370.PubMedCrossRef

Jones, P. W., Harding, G., Berry, P., Wiklund, I., Chen, W. H., & Leidy, K., N (2009). Development and first validation of the COPD Assessment Test. European Respiratory Journal, 34(3), 648–654.PubMedCrossRef

Kazdin, A. E. (2016). Single-case experimental research designs.

Kochanek, K. D., Murphy, S. L., Xu, J., & Arias, E. (2014). Mortality in the United States, 2013. Nchs Data Brief, 178(178), 1–8.

Lancaster, G. A., Dodd, S., & Williamson, P. R. (2004). Design and analysis of pilot studies: recommendations for good practice. Journal of evaluation in clinical practice, 10(2), 307–312.PubMedCrossRef

Leon, A. C., Davis, L. L., & Kraemer, H. C. (2011). The role and interpretation of pilot studies in clinical research. Journal of psychiatric research, 45(5), 626–629.PubMedCrossRef

Leventhal, A. M., Piper, M. E., Japuntich, S. J., Baker, T. B., & Cook, J. W. (2014). Anhedonia, depressed mood, and smoking cessation outcome. Journal of Consulting and Clinical Psychology, 82(1), 122–129.PubMedCrossRef

Leventhal, A. M., & Zvolensky, M. J. (2015). Anxiety, depression, and cigarette smoking: A transdiagnostic vulnerability framework to understanding emotion–smoking comorbidity. Psychological bulletin, 141(1), 176.PubMedCrossRef

Lindson, N., Klemperer, E., Hong, B., Ordóñez-Mena, J. M., & Aveyard, P. (2019). Smoking reduction interventions for smoking cessation.Cochrane database of systematic reviews(9).

Liu, Y., Greenlund, K. J., VanFrank, B., Xu, F., Lu, H., & Croft, J. B. (2022). Smoking Cessation Among US Adult Smokers With and Without Chronic Obstructive Pulmonary Disease, 2018. American journal of preventive medicine, 62(4), 492–502.PubMedPubMedCentralCrossRef

Mathew, A. R., Hogarth, L., Leventhal, A. M., Cook, J. W., & Hitsman, B. (2017). Cigarette smoking and depression comorbidity: systematic review and proposed theoretical model. Addiction, 112(3), 401–412.PubMedCrossRef

Mathew, A. R., Yount, S. E., Kalhan, R., & Hitsman, B. (2019). Psychological functioning in patients with chronic obstructive pulmonary disease: a preliminary study of relations with smoking status and disease impact. Nicotine and Tobacco Research, 21(5), 686–690.PubMedCrossRef

Mathew, A.R. & Cox, C.M. (2023). The Unified Protocol for smoking cessation: Conceptual basis and integrated treatment approach. In J. Osma & T.J. Farchione (Eds.), Applications of the Unified Protocol for Transdiagnostic Treatment of Emotional Dysregulation in Health Conditions. Oxford University Press.

Perkins, K. A., Karelitz, J. L., & Jao, N. C. (2013). Optimal carbon monoxide criteria to confirm 24-hr smoking abstinence. Nicotine & Tobacco Research, 15(5), 978–982.CrossRef

Piper, M. E. (2015). Withdrawal: Expanding a Key Addiction Construct.Nicotine & Tobacco Research,ntv048.

Powell, L. H., Kaufmann, P. G., & Freedland, K. E. (2021). Clinical Significance. Behavioral Clinical Trials for Chronic Diseases: Scientific Foundations (pp. 97–124). Cham: Springer International Publishing.CrossRef

Rigotti, N. A., Tindle, H. A., Regan, S., Levy, D. E., Chang, Y., Carpenter, K. M., & Reid, Z. Z. (2016). A post-discharge smoking-cessation intervention for hospital patients: helping hand 2 randomized clinical trial. American journal of preventive medicine, 51(4), 597–608.PubMedPubMedCentralCrossRef

Ruiz, C. A. J., Guerrero, A. M. C., Ulibarri, M. L. M., Fernandez, M. I. C., & Gonzalez, G. L. (2011). Phenotypic features in COPD smokers attending a smoking cessation unit.European Respiratory Journal, 38(Suppl 55), p1562.

Sauer-Zavala, S., Cassiello-Robbins, C., Conklin, L. R., Bullis, J. R., Thompson-Hollands, J., & Kennedy, K. A. (2017). Isolating the unique effects of the unified protocol treatment modules using single case experimental design. Behavior modification, 41(2), 286–307.PubMedCrossRef

Schauer, G. L., Wheaton, A. G., Malarcher, A. M., & Croft, J. B. (2014). Smoking prevalence and cessation characteristics among U.S. adults with and without COPD: findings from the 2011 Behavioral Risk Factor Surveillance System. COPD, 11(6), 697–704.PubMedCrossRef

Schauer, G. L., Wheaton, A. G., Malarcher, A. M., & Croft, J. B. (2016). Health-care Provider Screening and Advice for Smoking Cessation Among Smokers With and Without COPD: 2009–2010 National Adult Tobacco Survey. Chest, 149(3), 676–684.PubMedCrossRef

Schnoll, R. A., Leone, F. T., & Hitsman, B. (2013). Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patch. Journal of addictive diseases, 32(1), 46–52.PubMedPubMedCentralCrossRef

Shahab, L., Jarvis, M. J., Britton, J., & West, R. (2006). Prevalence, diagnosis and relation to tobacco dependence of chronic obstructive pulmonary disease in a nationally representative population sample. Thorax, 61(12), 1043–1047.PubMedPubMedCentralCrossRef

Shiffman, S., Balabanis, M. H., Gwaltney, C. J., Paty, J. A., Gnys, M., Kassel, J. D., & Paton, S. M. (2007). Prediction of lapse from associations between smoking and situational antecedents assessed by ecological momentary assessment. Drug And Alcohol Dependence, 91(2–3), 159–168.PubMedPubMedCentralCrossRef

Simons, J., Correia, C. J., Carey, K. B., & Borsari, B. E. (1998). Validating a five-factor marijuana motives measure: Relations with use, problems, and alcohol motives. Journal of Counseling Psychology, 45(3), 265.CrossRef

Stelmach, R., Fernandes, F. L., Carvalho-Pinto, R. M., Athanazio, R. A., Rached, S. Z., Prado, G. F., & Cukier, A. (2015). Comparison between objective measures of smoking and self-reported smoking status in patients with asthma or COPD: are our patients telling us the truth? J Bras Pneumol, 41(2), 124–132.PubMedPubMedCentralCrossRef

Stotts, A. L., Vujanovic, A., Heads, A., Suchting, R., Green, C. E., & Schmitz, J. M. (2015). The role of avoidance and inflexibility in characterizing response to contingency management for cocaine use disorders: A secondary profile analysis. Psychology of Addictive Behaviors, 29(2), 408.PubMedCrossRef

Thrul, J., Howe, C. L., Devkota, J., Alexander, A., Allen, A. M., Businelle, M. S., & Gordon, J. S. (2022). A Scoping Review and Meta-analysis of the Use of Remote Biochemical Verification Methods of Smoking Status in Tobacco Research. Nicotine & Tobacco Research.

Tilert, T., Dillon, C., Paulose-Ram, R., Hnizdo, E., & Doney, B. (2013). Estimating the US prevalence of chronic obstructive pulmonary disease using pre-and post-bronchodilator spirometry: the National Health and Nutrition Examination Survey (NHANES) 2007–2010. Respiratory Research, 14(1), 1.

van Eerd, E. A., van Rossem, C. R., Spigt, M. G., Wesseling, G., van Schayck, O. C., & Kotz, D. (2015). Do we need tailored smoking cessation interventions for smokers with COPD? A comparative study of smokers with and without COPD regarding factors associated with tobacco smoking. Respiration, 90(3), 211–219.PubMedCrossRef

Vestbo, J., Hurd, S. S., & Rodriguez-Roisin, R. (2012). The 2011 revision of the global strategy for the diagnosis, management and prevention of COPD (GOLD)--why and what? The Clinical Respiratory Journal, 6(4), 208–214.PubMedCrossRef

Vozoris, N. T., & Stanbrook, M. B. (2011). Smoking prevalence, behaviours, and cessation among individuals with COPD or asthma. Respiratory Medicine, 105(3), 477–484.PubMedCrossRef

Walach, H., Buchheld, N., Buttenmüller, V., Kleinknecht, N., & Schmidt, S. J. P. (2006). & differences, i. Measuring mindfulness—the Freiburg mindfulness inventory (FMI). 40(8), 1543–1555.

Westman, E. C., Behm, F. M., Simel, D. L., & Rose, J. E. (1997). Smoking behavior on the first day of a quit attempt predicts long-term abstinence. Archives of Internal Medicine, 157(3), 335–340.PubMedCrossRef

Yohannes, A. M., & Alexopoulos, G. S. (2014). Depression and anxiety in patients with COPD. European Respiratory Reviews, 23(133), 345–349.CrossRef

Titel: Development of a targeted behavioral treatment for smoking cessation among individuals with Chronic Obstructive Pulmonary Disease
Auteurs: Amanda R. Mathew
Elizabeth F. Avery
Chelsea Cox
Patrick Nwanah
Ravi Kalhan
Brian Hitsman
Lynda H. Powell
Publicatiedatum: 06-05-2023
Uitgeverij: Springer US
Gepubliceerd in: Journal of Behavioral Medicine / Uitgave 6/2023
Print ISSN: 0160-7715
Elektronisch ISSN: 1573-3521
DOI: https://doi.org/10.1007/s10865-023-00411-z

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Objective

Method

Results

Conclusions

Implications

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2023

Eliminating children’s tobacco smoke exposure: a pathway to bioverified abstinence among low-income maternal smokers in the Babies Living Safe and Smokefree (BLiSS) trial

Mapping the associations of daily pain, sleep, and psychological distress in a U.S. sample

Which measures of perceived vulnerability predict protective intentions—and when?

Alcohol use severity in relation to pain severity and interference among latinx adults with current pain who smoke cigarettes

Adversity type and timing predict temporal summation of pain in African-American adults

Death anxiety predicts fear of Cancer recurrence and progression in ovarian Cancer patients over and above other cognitive factors